Колистиметат Ромфарм

Колистиметат Ромфарм contains colistimethate sodium, an antibiotic used to treat bacterial infections. This medication is administered via intravenous, intrathecal, or intraventricular routes. It is manufactured by S.C. Rompharm Company S.R.L. in the EU.

Colistimethate sodium is primarily used to treat infections caused by susceptible gram-negative bacteria. It is often prescribed when other antibiotics are ineffective or contraindicated. This medication may be used for conditions such as pneumonia, urinary tract infections, or bloodstream infections. It is also used in cases where the infection is resistant to other treatments.

Colistimethate sodium works by disrupting the bacterial cell membrane, leading to cell death. Patients may experience relief from symptoms as the infection is targeted. Common effects include improved clinical signs of infection, such as reduced fever or pain, depending on the condition being treated.

This medication should only be used under the supervision of a healthcare professional. Patients should inform their doctor about any allergies, kidney issues, or neuromuscular disorders. Regular monitoring may be required to ensure safe and effective use. It is important to complete the full course of treatment as prescribed.

Colistimethate sodium may interact with other medications, including certain antibiotics, muscle relaxants, or drugs affecting kidney function. Alcohol use should be avoided during treatment. Patients should disclose all medications and supplements to their healthcare provider to prevent potential interactions.